Magnetic brain stimulation to help people with insomnia sleep better
Tests magnetic stimulation of the brain against sham stimulation in adults with insomnia.
Key facts
- Who runs it
- University of Arizona
- Where
- Tucson, United StatesSee the site
- Trial code
- Registry title
- Effectiveness of Transcranial Magnetic Stimulation of the Default Mode Network to Improve Sleep - Clinical Trial
- Status
- Recruiting
- People taking part
- 144 people, planned
- Started
- 23 Jun 2025
- Expected to end
- Aug 2027
- Type of study
- Interventional, 4 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Transcranial Magnetic Stimulation (TMS)
- Sham
- Record updated
- 4 November 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with moderate or worse insomnia. It tests brain stimulation with magnetic pulses (cTBS/TMS) or sham stimulation to improve sleep.
- Age
- 18 to 60 years
- Sex
- Men and women who are not pregnant
- Disease stage
- Insomnia disorder by DSM-5, confirmed by a sleep doctor, with an Insomnia Severity Index score of 15 or more (moderate or higher).
- Earlier treatment
- People who had a bad experience with brain stimulation before cannot join.
Main reasons for not taking part
- Metal implants or medical devices unsafe for MRI or TMS
- Sleep apnea or other sleep or breathing disorders besides insomnia
- Seizures in yourself or a close family member, or certain medicines that affect seizure risk
- Shift work in the past 6 months, or travel outside the time zone during the study
- Pregnancy, substance abuse, or more than 300 mg of caffeine a day
The registry criteria, word for word
Show all 20 criteriaShow less
Who can take part
- Healthy men and non-pregnant women 18-60 (inclusive) years of age free from contraindicated diseases, medications, devices, and conditions
- Must score in the moderate or higher range on the Insomnia Severity Index (ISI ≥ 15)
- Must meet the criteria for DSM-5 insomnia disorder as determined by a clinical interview with a board-certified sleep medicine physician
- Sex ratio will be set to ~50% males; ~50% females
- Ethnicity ratio will be set to ~29.5% who identify as a minority; ~70.5% who identify as white
Who cannot take part
- Presence of any metal implant or medical device that may pose a safety risk for MRI or TMS (permanent hearing aids, cochlear implants, medication infusion devices, brain stimulation devices, permanent retainer, etc.)
- Travel outside the time zone within the one week prior to the physical visit and at any point while active in the study (known to affect sleep)
- Regular shiftwork within 6-months prior to enrollment in the study (known to affect sleep)
- Prior spinal cord surgeries or any spinal/ventricular derivations
- Self-reported past or present medical diagnosis of sleep or breathing-related disorders such as sleep apnea other than insomnia (potential confounder)
- Self-reported past or present history of any seizures or seizure disorders or other contraindication to neurostimulation, for self or any first-degree relatives (safety concern)
- Self-reported current use of certain prescription medications that can either influence seizure threshold, or neuroimaging findings (safety concern and potential confounder)
- Self-reported history of repeated, recent, or severe fainting spell or syncope
- Confounder of Obstructive Sleep Apnea as measured by WatchPAT device at home
- Self-reported caffeine use in excess of 300 mg (e.g., approximately 8 caffeinated sodas or approximately 3-4 12-oz cups of coffee) per day on average (known to affect sleep; potential confounder)
- Self-reported or suspected substance abuse or dependence (safety concern; potential confounder)
- (Females only) Positive urine pregnancy result (Urine HCG Test results) (safety concern)
- Inability to read and sign the consent form (regulatory/ethical issue)
- Self-reported negative experience due to neurostimulation before
- Deviation from self-reported normal bedtime sleep schedules (bedtime between 9:00 pm and 1:00 am
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 60 years old?
Where in United States
- SCAN LabTucson, United StatesContact: William Killgore, Ph.D.Taking people
About the trial
What the trial wants to find out
The investigators propose to expand our previous work to test whether 10 repeated administrations of the cTBS procedure over a two-week period can lead to longer-term improvements in sleep, perhaps up to 3-months. For this 3-year study, 120 people with insomnia will be recruited to participate. There will be an initial screening, with the first consent form being for the screening questions, a psychological interview, and a one night at home sleep monitoring session with our equipment. If participants pass this first phase, they will reconsent for the main portion of the study. They will then undergo a physical examination, then a week-long at-home monitoring phase where they will wear a wristwatch sleep monitor as well as wear a portable brain wave monitor to bed each night to record sleep. Participants will continue to use this equipment throughout the treatment phase and for one week post treatment. After the first monitoring phase, each participant will be randomly assigned to one of four different conditions (i.e., 30 assigned to each group). Three of the conditions will involve cTBS focused on different brain locations (i.e., stimulation to the middle front, middle back, or side of the skull), while the fourth condition will provide inactive sham stimulation as a control. All participants will complete 10 treatment visits to the lab over two-to-three weeks, during which they will get a brief cTBS or sham stimulation each time. In addition, all participants will complete a brain scanning and cognitive testing session at the beginning and end of the two-to-three week treatment period. Participants will also complete 1-month and 3-month online follow-up assessments to examine long-term effects.
The 4 groups in the trial
- Active Stimulation - Posterior Cingulate CortexExisting treatment, for comparison
Active Stimulation targeted at the Posterior Cingulate Cortex
Treatment: Transcranial Magnetic Stimulation (TMS)
- Active Stimulation - Inferior Parietal LobuleExisting treatment, for comparison
Active Stimulation targeted at the Inferior Parietal Lobule
Treatment: Transcranial Magnetic Stimulation (TMS)
- Active Stimulation - Dorsomedial Prefrontal CortexExisting treatment, for comparison
Active Stimulation targeted at the Dorsomedial Prefrontal Cortex
Treatment: Transcranial Magnetic Stimulation (TMS)
- Sham StimulationSham treatment, for comparison
The TMS device will be placed to the head but no energy will be emitted.
Treatment: Sham
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effectiveness of Transcranial Magnetic Stimulation of the Default Mode Network to Improve Sleep - Clinical Trial
- Plain-language title
- Magnetic brain stimulation to help people with insomnia sleep betterGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT06631209, who can take part
- Record updated
- 4 November 2025